Efficacy and safety in patients treated with a novel radiofrequency balloon: a two centres experience from the AURORA collaboration.
Stefano BordignonIlaria MyShota TohokuAndreas RilligDavid SchaackShaojie ChenBruno ReißmannLukas UrbanekJun HirokamiTolga Han EfeRamin EbrahimiMahi ButtFeifan OuyangKyoung-Ryul Julian ChunAndreas MetznerBoris SchmidtPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
The RFB showed a high efficacy allowing for fast PVI procedures, and 60% of PVs could be isolated at the first application. Most safety events were recorded during the learning phase. An oesophageal temperature monitoring is suggested: oesophageal lesions were detected in 8% of patients.